Scarica l'app Stockscreener
2.33
4.51%
-0.11
Dopo l'orario di chiusura:
2.32
-0.01
-0.43%
Precedente Chiudi:
$2.44
Aprire:
$2.45
Volume 24 ore:
394.95K
Relative Volume:
0.83
Capitalizzazione di mercato:
$157.89M
Reddito:
-
Utile/perdita netta:
$-64.20M
Rapporto P/E:
-1.0837
EPS:
-2.15
Flusso di cassa netto:
$57,000
1 W Prestazione:
+1.30%
1M Prestazione:
+37.06%
6M Prestazione:
+68.84%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$2.26
$2.45
Intervallo di 1 settimana:
$2.12
$2.49
Portata 52W:
$1.05
$5.47
Climb Bio Inc Stock (CLYM) Company Profile
Nome
Climb Bio Inc
Settore
Industria
Telefono
1-866-857-2596
Indirizzo
20 WILLIAM STREET, WELLESLEY HILLS
Confronta CLYM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
2.33 | 151.11M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Iniziato | Robert W. Baird | Outperform |
| 2025-06-06 | Iniziato | Oppenheimer | Outperform |
| 2025-05-22 | Iniziato | BTIG Research | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
Climb Bio Inc Borsa (CLYM) Ultime notizie
Climb Bio, Inc. (CLYM)'s Technical Outlook is Bright After Key Golden Cross - sharewise.com
Statistical indicators supporting Climb Bio Inc.’s strengthPortfolio Performance Report & Long Hold Capital Preservation Plans - Newser
Is Climb Bio Inc. stock poised for growthGap Up & Smart Allocation Stock Tips - Newser
What MACD and RSI say about Climb Bio Inc.Analyst Downgrade & Weekly Setup with ROI Potential - Newser
Does Climb Bio Inc. have a sustainable dividend2025 Market WrapUp & Long Hold Capital Preservation Tips - khodrobank.com
What’s the outlook for Climb Bio Inc.’s sectorMarket Performance Summary & Low Risk Profit Maximizing Plans - khodrobank.com
Is Climb Bio Inc. reversing from oversold territory2025 Fundamental Recap & Free Community Consensus Stock Picks - Newser
Is Climb Bio Inc. showing signs of accumulation2025 Trade Ideas & Real-Time Stock Movement Alerts - Newser
Is Climb Bio Inc. still worth holding after the dipWeekly Risk Report & AI Based Buy and Sell Signals - Newser
Order flow analysis tools used on Climb Bio Inc.Weekly Stock Summary & Proven Capital Preservation Methods - Newser
What recovery options are there for Climb Bio Inc.IPO Watch & Fast Moving Market Watchlists - Newser
Can Climb Bio Inc. sustain earnings growth2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - khodrobank.com
Applying chart zones and confluence areas to Climb Bio Inc.Portfolio Risk Report & Smart Swing Trading Alerts - Newser
Does Climb Bio Inc. outperform in volatile marketsTrade Analysis Summary & Free Accurate Trade Setup Notifications - khodrobank.com
What’s the analyst consensus on Climb Bio Inc.July 2025 Price Swings & Daily Price Action Insights - khodrobank.com
Will Climb Bio Inc. benefit from geopolitical trendsMarket Performance Recap & Fast Entry and Exit Trade Plans - khodrobank.com
Applying Wyckoff theory to Climb Bio Inc. stock2025 Winners & Losers & Verified Technical Signals - Newser
Is Climb Bio Inc. forming bullish engulfing patternsJuly 2025 Opening Moves & Daily Profit Focused Stock Screening - khodrobank.com
Multi factor analysis applied to Climb Bio Inc.Sell Signal & AI Enhanced Trading Signals - Newser
What MACD and RSI say about Climb Bio IncTrade Analysis Summary & Verified Entry Point Detection - Newser
Climb Bio Inc. Uptrend in Early Stages Indicators Say YesPortfolio Update Summary & High Return Stock Watch Alerts - beatles.ru
Evaluating Climb Bio Inc. with trendline analysis2025 Market Overview & Weekly High Return Opportunities - Newser
Climb Bio Inc. stock daily chart insights2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
Pattern recognition hints at Climb Bio Inc. upsidePortfolio Gains Summary & High Accuracy Trade Signal Alerts - Newser
Is Climb Bio Inc. forming a reversal patternWall Street Watch & Long-Term Investment Growth Plans - Newser
How institutional ownership impacts Climb Bio Inc. stockJuly 2025 Trade Ideas & Fast Gaining Stock Reports - Newser
Comparing Climb Bio Inc. in custom built stock radarsNew Guidance & Low Risk Entry Point Tips - Newser
Market reaction to Climb Bio Inc.’s recent newsQuarterly Earnings Report & Long Hold Capital Preservation Plans - Newser
Is a relief rally coming for Climb Bio Inc. holdersGold Moves & Verified Momentum Stock Alerts - Newser
Why Climb Bio Inc. stock attracts strong analyst attention getLinesFromResByArray error: size == 0 - sisain.net
Climb Bio Inc Azioni (CLYM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Climb Bio Inc Azioni (CLYM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Pimblett Emily | SVP, Finance & CAO |
Jun 20 '25 |
Sale |
1.24 |
1,242 |
1,540 |
18,888 |
| Pimblett Emily | SVP, Finance & CAO |
Mar 20 '25 |
Sale |
1.31 |
1,199 |
1,571 |
15,130 |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Dec 19 '24 |
Sale |
2.02 |
1,235 |
2,495 |
11,329 |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Sep 20 '24 |
Sale |
8.18 |
1,191 |
9,741 |
7,564 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):